Angelini Pharma acquires ThermaCare® from GSK

Angelini Pharma has acquired the ThermaCare® global business rights from GSK.

The European Commission has formally approved a deal for GSK to sale its rights for ThermaCare® Heat Wraps globally (excluding North America) to Angelini Pharma.

The deal also includes the dedicated US manufacturing site for ThermaCare in Albany (Georgia).

Angelini S.p.a.
Viale Amelia 70, 00181 Roma
P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585
Ufficio del registro delle imprese: Roma
Capitale: € 165.000.000 I.V.

© Angelini S.p.a. - Tutti i diritti riservati